Hiroto Iinuma Selected Research

Oxolinic Acid

1/2021	A novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke.
10/2019	Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroto Iinuma Research Topics

Disease

2	Malignant Hyperthermia 01/2021 - 10/2019
1	Contracture 01/2021
1	Heat Stroke (Heatstroke) 01/2021
1	Central Core Myopathy (Central Core Disease) 10/2019

Drug/Important Bio-Agent (IBA)

2	Oxolinic AcidIBA 01/2021 - 10/2019
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021 - 10/2019
1	CationsIBA 01/2021
1	Halothane (Fluothane)FDA Link 01/2021
1	Isoflurane FDA LinkGeneric 01/2021
1	AcidsIBA 01/2021
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	CalciumIBA 10/2019

Therapy/Procedure

1	Anesthesia 01/2021